404 related articles for article (PubMed ID: 22315315)
1. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
Rajesh M; Bátkai S; Kechrid M; Mukhopadhyay P; Lee WS; Horváth B; Holovac E; Cinar R; Liaudet L; Mackie K; Haskó G; Pacher P
Diabetes; 2012 Mar; 61(3):716-27. PubMed ID: 22315315
[TBL] [Abstract][Full Text] [Related]
2. CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.
Mukhopadhyay P; Pan H; Rajesh M; Bátkai S; Patel V; Harvey-White J; Mukhopadhyay B; Haskó G; Gao B; Mackie K; Pacher P
Br J Pharmacol; 2010 Jun; 160(3):657-68. PubMed ID: 20590569
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis.
Rajesh M; Mukhopadhyay P; Bátkai S; Arif M; Varga ZV; Mátyás C; Paloczi J; Lehocki A; Haskó G; Pacher P
Geroscience; 2022 Jun; 44(3):1727-1741. PubMed ID: 35460032
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line.
El-Remessy AB; Rajesh M; Mukhopadhyay P; Horváth B; Patel V; Al-Gayyar MM; Pillai BA; Pacher P
Diabetologia; 2011 Jun; 54(6):1567-78. PubMed ID: 21373835
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
Rajesh M; Mukhopadhyay P; Bátkai S; Patel V; Saito K; Matsumoto S; Kashiwaya Y; Horváth B; Mukhopadhyay B; Becker L; Haskó G; Liaudet L; Wink DA; Veves A; Mechoulam R; Pacher P
J Am Coll Cardiol; 2010 Dec; 56(25):2115-25. PubMed ID: 21144973
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.
Rajesh M; Mukhopadhyay P; Haskó G; Liaudet L; Mackie K; Pacher P
Br J Pharmacol; 2010 Jun; 160(3):688-700. PubMed ID: 20590572
[TBL] [Abstract][Full Text] [Related]
7. Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.
Bátkai S; Rajesh M; Mukhopadhyay P; Haskó G; Liaudet L; Cravatt BF; Csiszár A; Ungvári Z; Pacher P
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H909-18. PubMed ID: 17434980
[TBL] [Abstract][Full Text] [Related]
8. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
[TBL] [Abstract][Full Text] [Related]
9. CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.
Mukhopadhyay P; Rajesh M; Bátkai S; Patel V; Kashiwaya Y; Liaudet L; Evgenov OV; Mackie K; Haskó G; Pacher P
Cardiovasc Res; 2010 Mar; 85(4):773-84. PubMed ID: 19942623
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury.
Mukhopadhyay P; Horváth B; Rajesh M; Matsumoto S; Saito K; Bátkai S; Patel V; Tanchian G; Gao RY; Cravatt BF; Haskó G; Pacher P
Free Radic Biol Med; 2011 Jan; 50(1):179-95. PubMed ID: 21070851
[TBL] [Abstract][Full Text] [Related]
11. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
Li CJ; Lv L; Li H; Yu DM
Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
[TBL] [Abstract][Full Text] [Related]
12. Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach.
Valenta I; Varga ZV; Valentine H; Cinar R; Horti A; Mathews WB; Dannals RF; Steele K; Kunos G; Wahl RL; Pomper MG; Wong DF; Pacher P; Schindler TH
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):320-332. PubMed ID: 29413441
[TBL] [Abstract][Full Text] [Related]
13. Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction.
Lei L; Hu H; Lei Y; Feng J
Biochem Biophys Res Commun; 2018 Nov; 506(3):668-673. PubMed ID: 30454704
[TBL] [Abstract][Full Text] [Related]
14. Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'.
Waldman M; Cohen K; Yadin D; Nudelman V; Gorfil D; Laniado-Schwartzman M; Kornwoski R; Aravot D; Abraham NG; Arad M; Hochhauser E
Cardiovasc Diabetol; 2018 Aug; 17(1):111. PubMed ID: 30071860
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
Wang Y; Zhou S; Sun W; McClung K; Pan Y; Liang G; Tan Y; Zhao Y; Liu Q; Sun J; Cai L
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1239-47. PubMed ID: 24714399
[TBL] [Abstract][Full Text] [Related]
16. Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.
Kain V; Kumar S; Sitasawad SL
Cardiovasc Diabetol; 2011 Nov; 10():97. PubMed ID: 22054019
[TBL] [Abstract][Full Text] [Related]
17. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids.
Yang YY; Liu H; Nam SW; Kunos G; Lee SS
J Hepatol; 2010 Aug; 53(2):298-306. PubMed ID: 20626112
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy.
Mano Y; Anzai T; Kaneko H; Nagatomo Y; Nagai T; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
Circ J; 2011; 75(7):1717-27. PubMed ID: 21519150
[TBL] [Abstract][Full Text] [Related]
20. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
